It has been two and a half years since the emergence of the SARS-CoV-2 virus and the COVID-19 outbreak. Despite the success of safe and efficacious vaccines for COVID-19, people still fall ill due to viral infection and the ensuing complications. With the continual emergence of SARS-CoV-2 variants of interest, the threat is far from over. In this webinar, Lianghui (Lucy) Zhang and Michael Cobas Meyer will discuss strategies employed by scientists to develop effective therapies for COVID-19.

Topics to be covered

• Targeting SARS-CoV-2 variants with an engineered protein decoy
• Using the monoclonal antibody, bebtelovimab against SARS-CoV-2 and variants of concern

Speakers